{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:50:51Z","timestamp":1793235051504,"version":"4.5.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T00:00:00Z","timestamp":1202860800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001578","type":"journal-article","created":{"date-parts":[[2008,2,12]],"date-time":"2008-02-12T18:52:01Z","timestamp":1202842321000},"page":"e1578","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Sulfadoxine-Pyrimethamine\u2013Based Combinations for Malaria: A Randomised Blinded Trial to Compare Efficacy, Safety and Selection of Resistance in Malawi"],"prefix":"10.1371","volume":"3","clinical-trial-number":[{"clinical-trial-number":"isrctn22075368","registry":"10.18810\/isrctn"}],"author":[{"given":"David J.","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzgo K.","family":"Nyirongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mavuto","family":"Mukaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed E.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Plowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm E.","family":"Molyneux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve A.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Winstanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,2,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/bmj.37977.653750.EE","article-title":"Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.","volume":"328","author":"CV Plowe","year":"2004","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa062032","article-title":"Return of chloroquine antimalarial efficacy in Malawi.","volume":"355","author":"MK Laufer","year":"2006","journal-title":"N Engl J Med"},{"key":"ref3","article-title":"Guidelines for the treatment of malaria.","year":"2006"},{"key":"ref4","article-title":"Antimalarial treatment policies for <italic>P.falciparum<\/italic> and <italic>P.vivax<\/italic> by country in WHO Africa region.","author":"P Olumese","year":"2007"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trstmh.2006.07.001","article-title":"Amodiaquine combined with sulfadoxine\/pyrimethamine versus artemisinin-based combinations for the treatment of uncomplicated falciparum malaria in Africa: a meta-analysis.","volume":"101","author":"CO Obonyo","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0035-9203(99)90083-4","article-title":"Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa.","volume":"93","author":"P Brasseur","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4269\/ajtmh.2003.68.127","article-title":"Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda.","volume":"68","author":"AF Gasasira","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0140-6736(86)92371-8","article-title":"Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria.","volume":"1","author":"CS Hatton","year":"1986","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/bmj.292.6522.721","article-title":"Amodiaquine induced agranulocytosis and liver damage.","volume":"292","author":"KA Neftel","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000016","article-title":"Amodiaquine for treating malaria.","author":"P Olliaro","year":"2003","journal-title":"Cochrane Database Syst Rev CD000016"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/422758","article-title":"Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones.","volume":"190","author":"AA Djimde","year":"2004","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1086\/375419","article-title":"Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.","volume":"187","author":"JG Kublin","year":"2003","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1086\/514159","article-title":"Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.","volume":"176","author":"CV Plowe","year":"1997","journal-title":"J Infect Dis"},{"key":"ref14","article-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria.","year":"2003"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2003.68.133","article-title":"Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp.","volume":"68","author":"A Cattamanchi","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/338566","article-title":"Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.","volume":"185","author":"JG Kublin","year":"2002","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1475-2875-6-57","article-title":"Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions.","volume":"6","author":"TO Abuya","year":"2007","journal-title":"Malar J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0166-6851(96)02655-2","article-title":"Amodiaquine accumulation in Plasmodium falciparum as a possible explanation for its superior antimalarial activity over chloroquine.","volume":"80","author":"SR Hawley","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(02)12021-6","article-title":"Sulfadoxine\/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.","volume":"360","author":"G Dorsey","year":"2002","journal-title":"Lancet"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4269\/ajtmh.2003.68.743","article-title":"Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.","volume":"68","author":"CE Rwagacondo","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0035-9203(93)90431-O","article-title":"Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life.","volume":"87","author":"WM Watkins","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.2006.75.155","article-title":"Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria.","volume":"75","author":"CT Happi","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/AAC.00875-06","article-title":"Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.","volume":"51","author":"GS Humphreys","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/AAC.00012-07","article-title":"Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda.","volume":"51","author":"SL Nsobya","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(07)60236-0","article-title":"Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.","volume":"369","author":"I Zongo","year":"2007","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/AAC.50.5.1893-1895.2006","article-title":"Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic.","volume":"50","author":"C Dokomajilar","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/427997","article-title":"In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem).","volume":"191","author":"C Sisowath","year":"2005","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1365-2958.2000.01914.x","article-title":"Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum.","volume":"36","author":"MT Duraisingh","year":"2000","journal-title":"Mol Microbiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1128\/AAC.49.9.3919-3921.2005","article-title":"Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.","volume":"49","author":"AP Alker","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/014107689008300208","article-title":"Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain.","volume":"83","author":"PA Phillips-Howard","year":"1990","journal-title":"J R Soc Med"},{"key":"ref31","first-page":"331","article-title":"Amodiaquine-induced agranulocytosis: drug inhibition of myeloid colonies in the presence of patient&apos;s serum.","volume":"21","author":"D Douer","year":"1985","journal-title":"Isr J Med Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(86)90908-6","article-title":"Neutropenia and prophylactic amodiaquine.","volume":"1","author":"R Carr","year":"1986","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/bmj.292.6522.717","article-title":"Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.","volume":"292","author":"EG Rhodes","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0163-4453(87)93130-6","article-title":"Neutropenia associated with dual antimalarial chemoprophylaxis--use of bone-marrow culture as an aid in further drug management.","volume":"15","author":"ME Ellis","year":"1987","journal-title":"J Infect"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T21:11:18Z","timestamp":1557263478000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001578"}},"subtitle":[],"editor":[{"given":"Aric","family":"Gregson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,2,13]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001578","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,13]]}}}